Compile Data Set for Download or QSAR
Report error Found 112 Enz. Inhib. hit(s) with all data for entry = 7408
TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193349BDBM193349(US9199927, 108 | US9199927, 60)
Affinity DataIC50: 0.140nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193350BDBM193350(US9199927, 61)
Affinity DataIC50: 0.140nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193317BDBM193317(US9199927, 28)
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193310BDBM193310(US9199927, 21)
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193313BDBM193313(US9199927, 24)
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193351BDBM193351(US9199927, 62)
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193290BDBM193290(US9199927, 1)
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193360BDBM193360(US9199927, 71)
Affinity DataIC50: 0.180nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193315BDBM193315(US9199927, 26)
Affinity DataIC50: 0.180nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193319BDBM193319(US9199927, 30)
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193290BDBM193290(US9199927, 1)
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193316BDBM193316(US9199927, 27)
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193349BDBM193349(US9199927, 108 | US9199927, 60)
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193304BDBM193304(US9199927, 15)
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193304BDBM193304(US9199927, 15)
Affinity DataIC50: 0.200nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193311BDBM193311(US9199927, 22)
Affinity DataIC50: 0.200nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193318BDBM193318(US9199927, 29)
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193369BDBM193369(US9199927, 80)
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193313BDBM193313(US9199927, 24)
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193349BDBM193349(US9199927, 108 | US9199927, 60)
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193349BDBM193349(US9199927, 108 | US9199927, 60)
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193303BDBM193303(US9199927, 14)
Affinity DataIC50: 0.220nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193414BDBM193414(US9199927, 96)
Affinity DataIC50: 0.220nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193305BDBM193305(US9199927, 16)
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193360BDBM193360(US9199927, 71)
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193303BDBM193303(US9199927, 14)
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193350BDBM193350(US9199927, 61)
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193395BDBM193395(US9199927, 113)
Affinity DataIC50: 0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193323BDBM193323(US9199927, 34)
Affinity DataIC50: 0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193317BDBM193317(US9199927, 28)
Affinity DataIC50: 0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193314BDBM193314(US9199927, 25)
Affinity DataIC50: 0.25nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193310BDBM193310(US9199927, 21)
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193319BDBM193319(US9199927, 30)
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193305BDBM193305(US9199927, 16)
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193316BDBM193316(US9199927, 27)
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193348BDBM193348(US9199927, 59)
Affinity DataIC50: 0.270nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193306BDBM193306(US9199927, 17)
Affinity DataIC50: 0.270nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193395BDBM193395(US9199927, 113)
Affinity DataIC50: 0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193312BDBM193312(US9199927, 23)
Affinity DataIC50: 0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193324BDBM193324(US9199927, 35)
Affinity DataIC50: 0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193311BDBM193311(US9199927, 22)
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193351BDBM193351(US9199927, 62)
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193415BDBM193415(US9199927, 102)
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193315BDBM193315(US9199927, 26)
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193314BDBM193314(US9199927, 25)
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193415BDBM193415(US9199927, 102)
Affinity DataIC50: 0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193369BDBM193369(US9199927, 80)
Affinity DataIC50: 0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetSerine protease 1(Human)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193341BDBM193341(US9199927, 52)
Affinity DataIC50: 0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193348BDBM193348(US9199927, 59)
Affinity DataIC50: 0.310nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

TargetTrypsinogen 16(Mouse)
Astellas Pharma

US Patent
LigandChemical structure of BindingDB Monomer ID 193330BDBM193330(US9199927, 41)
Affinity DataIC50: 0.310nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/20/2016
Entry Details
US Patent

Displayed 1 to 50 (of 112 total ) | Next | Last >>
Jump to: